Transcriptomics

Dataset Information

299

Gene expression analysis of breast cancer (HCC1954) and normal breast cells (HMEC)


ABSTRACT: While genetic mutation is a hallmark of cancer, many cancers also acquire epigenetic alterations during tumorigenesis including aberrant DNA hypermethylation of tumor suppressors as well as changes in chromatin modifications as caused by genetic mutations of the chromatin-modifying machinery. However, the extent of epigenetic alterations in cancer cells has not been fully characterized. Here, we describe the first complete methylome maps at single nucleotide resolution of a low-passage breast cancer cell line and primary human mammary epithelial cells. We find widespread DNA hypomethylation in the cancer cell, primarily at partially methylated domains (PMDs) in normal breast cells. Unexpectedly, genes within these regions are largely silenced in cancer cells. The loss of DNA methylation in these regions is accompanied by formation of repressive chromatin, with a significant fraction displaying allelic DNA methylation where one allele is DNA methylated while the other allele is occupied by histone modifications H3K9me3 or H3K27me3. Our results show a mutually exclusive and complementary relationship between DNA methylation and H3K9me3 or H3K27me3. These results suggest that global DNA hypomethylation in breast cancer is tightly linked to the formation of repressive chromatin domains and gene silencing, thus identifying a potential epigenetic pathway for gene regulation in cancer cells and suggesting a possible new approach toward the development of cancer therapeutics. mRNA-Seq of polyA-selected RNA from breast cancer HCC1954 and normal breast HMEC. 36 cycles of sequencing on Illumina platform.

ORGANISM(S): Homo sapiens  

SUBMITTER: Gary C Hon   Gary Chung Hon  Bing Ren 

PROVIDER: E-GEOD-29119 | ArrayExpress | 2011-09-16

SECONDARY ACCESSION(S): GSE29119SRP006726PRJNA142887

REPOSITORIES: GEO, ArrayExpress, ENA

altmetric image

Publications


While genetic mutation is a hallmark of cancer, many cancers also acquire epigenetic alterations during tumorigenesis including aberrant DNA hypermethylation of tumor suppressors, as well as changes in chromatin modifications as caused by genetic mutations of the chromatin-modifying machinery. However, the extent of epigenetic alterations in cancer cells has not been fully characterized. Here, we describe complete methylome maps at single nucleotide resolution of a low-passage breast cancer cell  ...[more]

Similar Datasets

2011-09-16 | E-GEOD-29120 | ArrayExpress
2011-09-16 | GSE29118 | GEO
2011-09-16 | GSE29069 | GEO
| GSE29127 | GEO
2011-03-31 | E-GEOD-26019 | ArrayExpress
2011-03-31 | E-GEOD-26038 | ArrayExpress
2015-05-09 | E-GEOD-58881 | ArrayExpress
2016-02-29 | E-GEOD-75067 | ArrayExpress
2015-05-09 | E-GEOD-58880 | ArrayExpress
2013-12-09 | E-GEOD-52477 | ArrayExpress